The Motley Fool Previous Page


ResMed Beats on Both Top and Bottom Lines

http://www.fool.com/investing/general/2013/01/25/resmed-beats-on-both-top-and-bottom-lines.aspx

Seth Jayson
January 25, 2013

ResMed (NYSE: RMD